(ENTA)—GILD’s COO John Milligan (on 3Q15 CC) said HCV payer contracts for 2016 are already solidified, and hence Milligan sees no effect on payer contracts from the recent V-Pak label change.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.